Home > Insider Trading > Filing (0001127602-12-003204)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884731	Ariad Pharmaceuticals Inc	ARIA	Biological Products, (No Disgnostic Substances) (2836)	223106987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242998	R Jay Lamarche	C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-01-27	26,900	$15.05	500,534	No	4	S	Direct
Common Stock	Acquisiton	2012-01-31	18,359	$0.00	518,893	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,696	Indirect	Wife

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2011.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.34, inclusive. The reporting person undertakes to provide to ARIAD Pharmaceuticals, Inc. ("ARIAD"), any security holder of ARIAD, or the staff the Security and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.